- Ownership hops held
- 1000
An absent edge means not yet observed — never does not exist.
CHANNEL THERAPEUTICS CORP
CHANNEL THERAPEUTICS CORP — US company (sec:0001919246). UBO chain traced 1000 hops, 8 owners. Every claim linked to its source.
Ownership resolves 1000 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
- CHANNEL THERAPEUTICS CORP
None in current sources.
1000-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
The full ownership trace on this subject — every hop to the ultimate owner, its filing history and sanctions exposure — as PDF and JSON, every claim linked to its source.
Everything we hold on CHANNEL THERAPEUTICS CORP, resolved and sourced — yours to keep, no subscription.
- UBO trace
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €149.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBOSTANDARD
- Full export (PDF + un-redacted JSON) & change alertsPREMIUM
People & control
11 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- Davis Todd CAlso holds roles at 6 other companies
- LIGAND PHARMACEUTICALS INCofficer
- PALVELLA THERAPEUTICS, INC.director
- LIGAND PHARMACEUTICALS INCdirector
- EINHORN ANDREW J.Also holds roles at 4 other companies
- COGNITION THERAPEUTICS INCofficer
- OSMOTICA PHARMACEUTICALS LTDofficer
- PDS Biotechnology Corpofficer
- Francis Knuettel IIAlso holds roles at 16 other companies
- Innovation1 Biotech Inc.officer
- CANFIELD MEDICAL SUPPLY, INC.director
- Beeline Holdings, Inc.director
- Greenleaf PeterAlso holds roles at 12 other companies
- Aurinia Pharmaceuticals Inc.officer
- Aurinia Pharmaceuticals Inc.director
- ANTARES PHARMA INCdirector
- LIGAND PHARMACEUTICALS INCAlso holds roles at 79 other companies
- Reardon Andrewofficer
- Espinoza Octavioofficer
- Davis Todd Cofficer
- Pauls MatthewAlso holds roles at 7 other companies
- SOLENO THERAPEUTICS INCdirector
- Savara Incofficer
- Savara Incdirector
11 parties · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns CHANNEL THERAPEUTICS CORP?
- What is CHANNEL THERAPEUTICS CORP's risk level?
- Where does CHANNEL THERAPEUTICS CORP appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for CHANNEL THERAPEUTICS CORP — nothing is disclosed before that.